Centralyze
- Academic, tech transfer
- Digital health
- Investor (buy-side or sell-side research)
- Medical device or technology
- Biotech or pharma, therapeutic R&D
Centralyze Ventures accelerates university-derived biomedical innovations into high-impact companies. We partner closely with the University of Newcastle (UON) and world-class collaborators—most notably Harvard University—to spin out technologies, secure funding and drive them to clinical and commercial milestones. With over 20 years of biotech investment and strategy experience, I lead company creation, strategic partnerships and financing, bridging the gap between academic research and global markets.
Why Meet with Centralyze?
- ShearFlow (Nanonitrate) – a first-in-class, nanoparticle therapeutic with targeted efficacy in stroke.
- HiFi Ortho – AI-driven orthopaedic implant production system with in-hospital revenue and regulatory clearance ready to scale globally.
- Centralyze - Leverage Centralyze’s deep networks in Australia, and Asia Pacific—alongside our commercialisation & market entry expertise—to accelerate product launch, secure strategic alliances and drive revenue growth.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}